These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34811411)

  • 1. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY).
    Krebs J; Mansi T; Delingette H; Lou B; Lima JAC; Tao S; Ciuffo LA; Norgard S; Butcher B; Lee WH; Chamera E; Dickfeld TM; Stillabower M; Marine JE; Weiss RG; Tomaselli GF; Halperin H; Wu KC; Ashikaga H
    Sci Rep; 2021 Nov; 11(1):22683. PubMed ID: 34811411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
    J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Heart; 2016 Jun; 102(11):832-40. PubMed ID: 26843532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.
    Demirel F; Adiyaman A; Timmer JR; Dambrink JH; Kok M; Boeve WJ; Elvan A
    Int J Cardiol; 2014 Dec; 177(2):392-9. PubMed ID: 25440471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J; Porter B; Claridge S; Chen Z; Sieniewicz BJ; Sidhu BS; Niederer S; Bishop MJ; Murgatroyd F; Ganeshan B; Carr-White G; Razavi R; Chiribiri A; Rinaldi CA
    Heart Rhythm; 2019 Aug; 16(8):1242-1250. PubMed ID: 30849532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
    Olimulder MA; Kraaier K; Galjee MA; Scholten MF; van Es J; Wagenaar LJ; van der Palen J; von Birgelen C
    Int J Cardiovasc Imaging; 2013 Jan; 29(1):169-76. PubMed ID: 22684301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.
    Alexandre J; Saloux E; Dugué AE; Lebon A; Lemaitre A; Roule V; Labombarda F; Provost N; Gomes S; Scanu P; Milliez P
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):12. PubMed ID: 23331500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P; Quinto L; Garre P; Zaraket F; Alarcón F; Borràs R; Caixal G; Vázquez S; Prat S; Ortiz-Perez JT; Perea RJ; Guasch E; Tolosana JM; Berruezo A; Arbelo E; Sitges M; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Aug; 18(8):1336-1343. PubMed ID: 33892202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
    Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
    Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
    Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry.
    Pontone G; Guaricci AI; Fusini L; Baggiano A; Guglielmo M; Muscogiuri G; Volpe A; Abete R; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Martini C; Marzo F; Masi A; Memeo R; Moro C; Nese A; Palumbo A; Pavon AG; Pedrotti P; Marra MP; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Masci PG; Schwitter J
    JACC Cardiovasc Imaging; 2023 Nov; 16(11):1387-1400. PubMed ID: 37227329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy.
    Alkharaza A; Al-Harbi M; El-Sokkari I; Doucette S; MacIntyre C; Gray C; Abdelwahab A; Sapp JL; Gardner M; Parkash R
    BMC Cardiovasc Disord; 2020 Oct; 20(1):455. PubMed ID: 33087069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation.
    Shah R; Sharma A; Assis F; De Vasconcellos HD; Alugubelli N; Pandey P; Akhtar T; Gasperetti A; Zhou S; Halperin H; Zimmerman SL; Tandri H; Kolandaivelu A
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):411-421. PubMed ID: 36331683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z; Sohal M; Voigt T; Sammut E; Tobon-Gomez C; Child N; Jackson T; Shetty A; Bostock J; Cooklin M; O'Neill M; Wright M; Murgatroyd F; Gill J; Carr-White G; Chiribiri A; Schaeffter T; Razavi R; Rinaldi CA
    Heart Rhythm; 2015 Apr; 12(4):792-801. PubMed ID: 25533585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.
    Tülümen E; Rudic B; Ringlage H; Hohneck A; Röger S; Liebe V; Kuschyk J; Overhoff D; Budjan J; Akin I; Borggrefe M; Papavassiliu T
    Heart Rhythm; 2021 Jun; 18(6):954-961. PubMed ID: 33515714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.